NCT05914116 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Request Content

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID	NCT05914116
Title	A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	No
Sponsors	DualityBio Inc.
Indications	hepatocellular carcinoma fallopian tube cancer castration-resistant prostate carcinoma head and neck squamous cell carcinoma ovary serous adenocarcinoma prostate cancer Advanced Solid Tumor esophagus squamous cell carcinoma lung non-small cell carcinoma cervical adenosquamous carcinoma lung small cell carcinoma ovary epithelial cancer cervical squamous cell carcinoma prostate adenocarcinoma peritoneum cancer cervical adenocarcinoma melanoma
Therapies	DB-1311 + Enzalutamide Abiraterone + DB-1311 DB-1311
Age Groups:	senior \| adult
Covered Countries	USA \| AUS

No variant requirements are available.